Guanidinoacetate Methyltransferase Deficiency
Oncology·MeSH: Guanidinoacetate methyltransferase deficiency
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Guanidinoacetate Methyltransferase Deficiency?
There are 1 clinical trial targeting Guanidinoacetate Methyltransferase Deficiency tracked by BioSniper.
What is the prevalence of Guanidinoacetate Methyltransferase Deficiency?
The estimated prevalence of Guanidinoacetate Methyltransferase Deficiency is approximately 0.1 per 100,000 population.
Deep-dive into Guanidinoacetate Methyltransferase Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis